Rely Health的动态

In response to the Opioid epidemic and the rising number of overdoses, Quality Behavioral Health, Inc. (QBH) has decided to expand its network in Macomb County. QBH acquired a facility at 15000 East 10 Mile Road that is on almost an acre lot that will serve as an Opioid Intervention Center. QBH plans to do the following at this location: ? Start an outpatient treatment center with MAT services that will be open 24 hours a day, 7 days a week. ? Make this center a walk-in/drop-in center for individuals in crisis who need immediate SUD or OUD intervention. ? Mobile MAT unit will dispense FDA approved medications including Methadone. ? Provide referrals and transportation as needed.

Pennsylvania is taking a big step toward improving healthcare by investing $3 million in integrating behavioral and primary care. This initiative will enhance access to coordinated care, particularly for those facing substance use disorders and chronic conditions. #BehavioralHealth #PrimaryCare #PublicHealth

The ECHO Model (Extension for Community Healthcare Outcomes--- (https://lnkd.in/gVW2YQ6T) Has Been Increasingly Used to Extend the Capability of Primary Care Teams to Address Opioid Use Disorders (OUD). As I posted a few months ago, Minnesota was an early adopter of this approach. Check-out a recent assessment of a similar initiative in Illinois. https://lnkd.in/ge2ir2HH

"This policy emphasizes the importance of providing multiple entry points into the healthcare system for individuals struggling with OUD, whether it be through emergency rooms, primary care settings, or community-based organizations." Link in comment #MAT #ChronicMedicalCondition #PromoteComprehensiveApproaches #PrimaryCareSettings #ImportantEntryPoint #EmergencyRoomSetting #TreatmentsRemainsLimited #AchieveLongTermRecovery #OfferingNonJudgmentalSupport #ProvidingNonJudgmentalCare

Dive deep into the latest changes impacting substance use disorder treatment regulations. We wrote our blog, "Understanding SAMHSA's Key Changes to 42 CFR Part 8," to be your guide for navigating these shifts. Stay ahead of the curve, empower your practice, and make a difference in patient care! #Healthcare #RegulatoryChanges #SAMHSA #SubstanceUseDisorder https://lnkd.in/eM3zPUYK

This webinar is free and offers CME and CEU credits! Stigma can prevent people from seeking help, getting diagnosed, or receiving treatment.?It can also lead to substandard care, denial of care, or passing care off to less experienced staff,?contributing to health disparities by influencing health outcomes. Research shows that stigma is one of the primary barriers to accessing recovery services for people who use substances. There's still time to join CareOregon's MEDS Ed program as we present psychiatric nurse practitioner Lydia Bartholow, DNP, PMHNP, CARN-AP, reviewing the types of stigma that patients are likely to experience, how the media informs stigma, and how race, gender, sexuality and class modify the impact of stigma. Special emphasis on how stigma is a barrier to evidence-based medical care for people with substance use disorders, as well as actionable steps we can all take to decrease stigma and improve health outcomes for vulnerable Oregonians. https://lnkd.in/gEGxdE8z

Happy to announce an article I am a co-author on has been published in Drug and Alcohol Dependence Reports! Our research, titled "Perceptions of structural and provider-based substance use stigma interventions among primary care professionals", explored the crucial issues of substance use stigma in healthcare. In collaboration with an incredible team, we examine how primary care professionals perceive various interventions aimed at reducing stigma associated with substance use. Our findings highlight the importance of addressing both structural and provider-based factors to improve care and outcomes for individuals with substance use disorders. https://lnkd.in/eBpK77xz #PublicHealth #Research #SubstanceUse #StigmaReduction

Medicaid Managed Care Coverage for Substance Use Disorder Treatment In this class, we delve into the intricacies of Medicaid policies and utilization management, focusing specifically on substance use disorder treatment. Led by speakers Dr. Christina Andrews and Dr. Amanda J. Abraham, this seminar promises valuable insights and actionable learning, including these objectives: - Understand Medicaid coverage and utilization management policies related to substance use disorder treatment. - Identify trends in coverage across different treatment services and medications. - Explore the effects of Medicaid coverage restrictions on patient access to treatment. Speakers: Dr. Andrews: Focused on the organization and financing of substance use disorder treatment, Dr. Andrews is a leading researcher on strategies to address the opioid epidemic. Her work has been published in scientific journals and received awards, including the 2016 Breakthrough Star Award from USC for her research excellence as early-career faculty. Dr. Abraham: As an Associate Professor of Public Administration and Policy, Dr. Abraham's research focuses on the impact of federal and state policy on the accessibility and quality of substance use disorder treatment, particularly within the Medicaid and Medicare populations. Her contributions have been pivotal in shaping policy discussions in this critical area. Learn about Medicaid's role in access to substance use disorder treatment. View this CME class on demand today at the link below: https://buff.ly/4bjrs3U Funding for this initiative was made possible by grant no. 1H79TI085588 from SAMHSA. --- #AOAAM #SubstanceUseDisorder #MedicaidCoverage #CME #MedicaidCME

Technology has opened new ways for individuals to engage with healthcare providers, but non-adherence to treatment continues to be one of the most challenging aspects of behavioral health. Over half of those with a serious mental illness are not adhering to therapeutic treatment, according to a 2020 systematic review. It is not enough for individuals to find their way to a healthcare provider, they must be able to fill, pay for, and confidently take prescription drugs as directed by their care team. Non-adherence can lead to serious complications, increased hospitalizations, episodes of violence, a higher risk of suicide and other crises situations. At Altruix, we break down barriers to access and adherence, helping individuals get and take their medications. Read in this article by Altruix Chief Clinical Officer Thom Stambaugh four ways to accelerate access: https://hubs.la/Q02zZD9Z0 #access #adherence

HRSA Announces Nearly $50 Million Initiative To Support Opioid Treatment and Recovery Services in Rural Communities On March 6, White House Domestic Policy Advisor Neera Tanden joined HRSA and more than 900 rural health stakeholders to announce the Rural Opioid Treatment and Response Initiative and released the initiative’s funding application. The initiative will increase access to medications, expand support for the rural substance use disorder workforce, and facilitate supportive employment opportunities for individuals in recovery. Administrator Johnson emphasized “Treatment works, and recovery is possible, which is why our new HRSA Rural Opioid Treatment and Recovery Initiative prioritizes building and expanding access to opioid use disorder treatment and recovery services in rural communities.”? White House Domestic Policy Advisor Tanden discussed the Biden-Harris Administration’s support for expanding access to evidence-based prevention, harm reduction, treatment, and recovery services; increasing access to medications for opioid use disorder; and new reimbursement options through the Centers for Medicare & Medicaid Services for non-clinical providers, marriage and family therapists, and mental health counselors.